| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0008 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.42 | 0.004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |